CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0270
+0.000405 (1.52%)
At close: May 18, 2026

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
111269236223
Market Cap Growth
-75.80%-87.73%-83.24%-70.89%6.05%-
Enterprise Value
891470236-
Last Close Price
0.030.07120.0022000.0020540.6019820.00
PB Ratio
-0.12-0.26-6.081574.06-21.45-29.01
Debt / Equity Ratio
-0.06-0.13-0.8367.45-0.06-
Net Debt / Equity Ratio
0.030.160.8932.60-0.020.14
Net Debt / EBITDA Ratio
0.010.050.11-0.20--
Quick Ratio
0.080.180.440.430.0211.20
Current Ratio
0.140.300.500.561.3813.88
Return on Assets (ROA)
-241.15%-253.00%-178.66%-20.20%-1.63%-
Return on Capital Employed (ROCE)
215.60%366.00%1355.00%-474.00%-25.00%-0.30%
Earnings Yield
-8323.55%-1409.96%-72.13%-10.61%-0.28%-0.24%
Buyback Yield / Dilution
-19215.02%-16477.89%----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.